Fungal Otitis Externa Market
- 2026 年市場規模
- USD 195.43 Mn
- 2033 年預估規模
- USD 238.73 Mn
- 年複合成長率 CAGR
- 2.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Fungal Otitis Externa Market, By Drug Type (Ear Drops (Clotrimazole, Fluconazole, Acetic Acid (2%)), Oral Medications (Itraconazole, NSAIDS), Topical Medications, Late Stage Pipeline Drugs), By Fungus Type (Aspergillus, Candida), By Route of Administration (Otic, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Fungal otitis externa is an infection of the outer ear canal. Fungal otitis externa mostly affects people who live in warm or tropical areas. It also often affects people who swim frequently, live with diabetes, or have other chronic medical and skin conditions. The Symptoms of otitis externa include ear pain, itchiness in the ear canal, a discharge of liquid or pus from the ear and some degree of temporary hearing loss. Otitis externa is relatively common. It's estimated that around 1 in 10 people will be affected by it at some point in their lives.
Market Dynamics
Robust product pipeline for the treatment of fungal otitis externa which are expected to launch during the forecast period is anticipated to drive the growth of the global fungal otitis externa market. For instance, on July 8, 2020, Hill Dermaceuticals, Inc., a U.S.-based pharmaceutical company, initiated a phase II/III Study of the efficacy and safety of miconazole oil versus vehicle oil in the treatment of otomycosis, followed by an open-label safety evaluation. The study is estimated to be completed by December 2021. Furthermore, increasing prevalence of fungal otitis externa is expected to lead to high demand for various treatment therapy. For instance, according to the Sandoz, a subsidiary of Novartis AG, over 80% of the U.S. children experience at least one ear infection by their third birthday. Moreover, according to the American Academy of Family Physicians, the Fungi are identified in about 10% of cases of otitis externa. The most common pathogen is Aspergillus (80 to 90% of cases), followed by Candida.
Key features of the study:
• This report provides in-depth analysis of the global fungal otitis externa market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global fungal otitis externa market based on the following parameters – Company Highlights, Product Portfolio, Key Highlights, Financial Performance, Market Strategies
• Key companies covered as a part of this study include Novartis, Bayer AG, Sanofi, GlaxoSmithKline plc., AbbVie, Par Pharmaceutical, Inc., Hi-Tech Pharma, Actavis Mid-Atlantic, Hill Dermaceuticals Inc, NuLife Pharmaceuticals, Glenmark Pharmaceuticals Limited, Pfizer Inc., Janssen Pharmaceutical, McNeil Consumer Healthcare, Mylan N.V., and Salvat Laboratories
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global fungal otitis externa market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fungal otitis externa market
Market Segmentation
• By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Ear Drops
Clotrimazole
Fluconazole
Acetic Acid (2%)
o Oral Medications
Itraconazole
NSAIDS
o Topical Medications
o Late Stage Pipeline Drugs
• By Fungus Type Insights (Revenue, USD Mn, 2021 - 2033)
o Aspergillus
o Candida
• By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Otic
o Oral
o Topical
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players in the Fungal Otitis Externa Market
o Novartis
o Bayer AG
o Sanofi
o GlaxoSmithKline plc.
o AbbVie, Par Pharmaceutical, Inc.
o Hi-Tech Pharma
o Actavis Mid-Atlantic
o Hill Dermaceuticals Inc.
o NuLife Pharmaceuticals
o Glenmark Pharmaceuticals Limited
o Pfizer Inc.
o Janssen Pharmaceutical
o McNeil Consumer Healthcare
o Mylan N.V.
o Salvat Laboratories
o Others
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Fungus Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o PEST Analysis
o Industry Trends
o Pipeline Analysis
o Regulatory Scenario
o Reimbursement Scenario
o Epidemiology
o Drug Price List
o Treatment Algorithm
o Physicians Preferences and Views
o Global Supply Chain Analysis
o U.S. Total Diagnosed Patients With Fungal Otitis Externa, By Age Group
o U.S. Patient Rate Of Fungal Otitis Externa, By Season
o SVT-15652 Market Value & Volume Forecast- Global
o Insights and Methodology
4. Global Fungal Otitis Externa Market, By Drug Type, 2021 – 2033, (USD Million) and Volume (No. of Units)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Ear Drops
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million) and Volume (No. of Units)
o Clotrimazole
o Fluconazole
o Acetic Acid (2%)
o Oral Medications
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million) and Volume (No. of Units)
o Itraconazole
o NSAIDS
o Topical Medications
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million) and Volume (No. of Units)
o Late Stage Pipeline Drugs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million) and Volume (No. of Units)
5. Global Fungal Otitis Externa Market, By Fungus Type, 2021 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Aspergillus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Candida
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
6. Global Fungal Otitis Externa Market, By Route of Administration, 2021 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Otic
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Topical
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
7. Global Fungal Otitis Externa Market, By Distribution Channel, 2021 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
o Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
8. Global Fungal Otitis Externa Market, By Region, 2021 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o UK
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million) and Volume (No. of Units)
Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Million)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Novartis
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Sanofi
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
GlaxoSmithKline plc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
AbbVie
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Par Pharmaceutical, Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Hi-Tech Pharma
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Actavis Mid-Atlantic
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Hill Dermaceuticals Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
NuLife Pharmaceuticals
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Glenmark Pharmaceuticals Limited
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Pfizer Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Janssen Pharmaceutical
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
McNeil Consumer Healthcare
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Mylan N.V.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Salvat Laboratories
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
10. Section
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們